Medication Adherence

Resource Center

Polls

adherence

07/29/2020

Researchers recently asked patients with rheumatoid arthritis and their physicians about the biggest hurdles they face in controlling the disease. Take our poll to express your opinion on this issue.

07/29/2020

Research Summaries

FDA Alert

FDA Approves First Treatment for Adults With NASH, Serious Liver Disease

03/21/2024

Anthony Calabro, MA

The FDA approved resmetirom for the treatment of adults with noncirrhotic non-alcoholic steatohepatitis with moderate-to-advanced liver fibrosis.

03/21/2024

FDA ALERT

FDA Approves Nedosiran for Patients 9 Years of Age and Older With Primary Hyperoxaluria Type 1

01/29/2024

Anthony Calabro, MA

The once-monthly RNA interference injection medication received FDA approval based on results from the phase II PHYOX2 clinical trial and phase III PHYOX3 extension study.

01/29/2024

Research Summary

Among Patients With Atherosclerotic Cardiovascular Disease Who Are Eligible For High-Intensity Statins, Most Are Not Using Them

01/26/2024

Jessica Ganga

Researchers evaluated whether patients with atherosclerotic cardiovascular disease (ASCVD) are utilizing high-intensity statins in their routine care of the disease.

01/26/2024

Research Summary

Pausing Adjuvant Endocrine Therapy to Attempt Pregnancy Shows No Additional Short-Term Risk For Select Women With Early-Stage Breast Cancer

01/12/2024

Anthony Calabro, MA

In a single-group trial, researchers assessed the safety and risks associated with interrupting endocrine therapy for women with stage I, II, or III breast cancer attempting pregnancy.

01/12/2024

research summary

research summary

Directly Observed Therapy Accurately Measures PrEP Adherence

09/26/2023

Leigh Precopio

Pre-exposure prophylaxis (PrEP) adherence continues to be one of the main challenges for the elimination of HIV transmission. Researchers tested the use of an automated directly observed therapy...

09/26/2023

April 2024

Current Issue

April 2024

Volume 64

Issue 4